|
|
|
|
|
Coalition on Abortion/Breast Cancer
|
|
(Outlook
users please view this in a full screen.)
Susan G. Komen Has Two Moral Problems
By Karen
Malec
Coalition on Abortion/Breast Cancer
October 16, 2014
Last week, the National Catholic
Register published an article
by Judy Roberts discussing the moral dilemma that the breast cancer
fundraising organization, Susan G. Komen for the Cure, is facing.[1]
The article illustrates that Komen’s moral problems are really
two-fold. They arise from Komen’s complete surrender to the unbending
demands of secular society’s politically correct, civil religion
which insists the sexual revolution must continue, regardless of the
costs to human life.
In late January of 2012, when Komen decided it would stop giving
grants to Planned Parenthood, it folded within only three days after
the abortion giant exercised its political muscle by subjecting the
charity to its bully tactics.[2]
The other half of Komen’s (and other cancer groups’) moral deficiency
has to do with its failure to warn women on a timely basis about
breast cancer risks associated with induced abortion and use of
steroids, i.e. the birth control pill—also known as combined
(estrogen plus progestin) oral contraceptives—and combined hormone
replacement therapy (HRT) used for menopausal symptoms.
Abortion & Breast Cancer
The so-called charity denies the abortion-breast cancer (ABC) link,
although delayed first full term pregnancy, small family size, childlessness
and little or no breastfeeding are listed as accepted risk factors
for the disease in standard medical texts. There is nothing
charitable about misleading women about deadly health risks, so we
hate to call Komen a charity.
Two lists of epidemiological
studies on the ABC link are available on our website, but
not on Komen’s website. To give our readers a sense of the impact the
link the link is expected to have on women, our science adviser,
Professor Joel Brind (Baruch College, City University of New York)
reported to us in June, 2014 that:
“Since 2007, there have been published, for example, 17 studies in
Asia in addition to those 36 Chinese studies summarized by (Dr. Yubei
Huang and his colleagues in 2013). All 17 show increased risk, one as
high as 20-fold, with an average risk increase exceeding fourfold.
Just the recent data alone is totally compelling....At this rate,
the abortion-breast cancer link will kill millions in India and
China alone.” (emphasis added)
The Birth Control Pill & Breast Cancer
Evidence supporting a link between the pill and breast cancer dates
from at least 1975 when Fasal and Paffenbarger reported that users of
the pill for 2-4 years significantly increased their breast cancer
risk by 1.9 times. If they were still using the pill when they
entered the study, the 2-4 year users’ risk elevation climbed to
2.5-fold.[3]
Lees’ team reported in 1978 that recent users of the pill with a
prior breast biopsy increased their risk by five times; but among
women with a prior breast biopsy who’d used the pill for more than
five years, their risk increased nine-fold.[4]
Concerns about a pill-breast cancer link were discussed in the British
Medical Journal as early as 1964 when a physician, JJ. Shipman,
wrote a letter to the journal about patients who’d been taking the
pill and later developed the disease.[5] Another correspondent responded
in his letter that health authorities had been concerned about a
possible connection between use of estrogens and breast cancer since
approximately 1939.[6]
Combined Hormone Replacement Therapy & Breast Cancer
Evidence for the HRT-breast cancer link dates from 1987 when Hunt’s
team found that “Breast cancer incidence was also significantly
increased” by 1.59 times in users of menopausal therapy.[7]
Mills’ team reported in a 1989 study for the journal, Cancer,
a statistically significant 1.69-fold risk increase among HRT
users.[8]
In their 1988 study published in the European Journal of Cancer
and Clinical Oncology, esteemed scientists T.J. Key and M.C. Pike
explained that women reduce their breast cancer risk when they go
into menopause at a young age. That happens because the ovaries
decrease their production of estrogen and progesterone.[9] These are
hormones known to stimulate the division of breast cells. The authors
argued that:
“The protective effect of early menopause shows that ovarian hormones
increase the risk of breast cancer: it is likely that this is because
they stimulate breast cell division.”[9]
So it made good biological sense that HRT use would raise breast
cancer risk. When physicians prescribed HRT to women who’d entered
menopause at a young age, they deprived their patients of the
risk-reducing effect of early menopause.
Women Learned the Truth from the Press, Not Cancer Groups
Nevertheless, women only learned of the breast cancer risk associated
with the use of HRT accidentally when a story broke in the national
news in 2002 that the Women’s Health Initiative study had been
stopped prematurely because study subjects using HRT were dying of
heart attacks and strokes.[10]
That’s when journalists learned about a 26% increased risk of
invasive breast cancer associated with use of HRT. Cancer “charities”
weren’t the first to reveal that simple, but deadly, fact that
scientists had known for years. The national press did.
Nearly one-half of all HRT consumers in the U.S. stopped using those
menopausal hormones and breast cancer incidence declined markedly
within a year. Scientists reported a 7% decline in breast cancer
rates for 2003.[11]
Once HRT “fell,” the pill necessarily had to “fall” as well—although
that was a bitter pill for the sexual revolution’s devotees to
swallow. Both include the same type of drugs, but the pill contains a
larger dose. Therefore, cancer “charities” were forced to acknowledge
the pill as a risk factor on their websites, although they did so
quietly, without the same fanfare associated with the news about HRT;
and they downplayed the risk.
Save a life during Breast Cancer Unawareness Month by sharing our
newsletter with your family and friends.
References:
- “Susan G. Komen’s moral dilemma,” by Judy
Roberts, National Catholic Reporter, October 5, 2014.
Available at: <http://www.ncregister.com/daily-news/susan-g.-komens-moral-dilemma/>.
- “Did Komen reverse its position to stop
funding Planned Parenthood?” by Karen Malec, newsletter,
Coalition on Abortion/Breast Cancer. February 3, 2012. Available
at: <http://www.abortionbreastcancer.com/news/120203.htm>.
- Fasal E, Paffenbarger RS Jr. Oral
contraceptives as related to cancer and benign lesions of the
breast. J Natl Cancer Inst 1975;55(4):767-773.
- 4.Lees AW, Burns PE, Grace M. Oral
contraceptives and breast disease in premenopausal Northern
Albertan women. Int J Cancer 1978;22(6):700-707.
- Shipman JJ. Oral contraceptives and breast
cancer. Br Med J 1964;2(5409):629.
- Stoll BA, Oral contraceptives and breast
cancer. Br Med J 1964;2(5413):875.
- Hunt K, Vessey M, McPherson K, Coleman M.
Long-term surveillance of mortality and cancer incidence in
women receiving hormone replacement therapy. Br J Obstet
Gynaecol 1987;94(7):620-635.
- 8.Mills PK, Beeson WL, Phillips RL, Fraser
GE. Prospective study of exogenous hormone use and breast cancer
in Seventh-day Adventists. Cancer 1989;64(3):591-597.
- Key TJ, Pike MC. The role of oestrogens and
progestagens in the epidemiology and prevention of breast
cancer. Eur J Cancer Clin Oncol 1988;24(1):29-43.
- Writing group for the Women’s Health
Initiative Investigators. Risks and benefits of estrogen plus
progestin in healthy postmenopausal women. Principal Results
from the Women’s Health Initiative Randomized Controlled Trial. JAMA
2002;288(3):321-333.
- Schneider AP, Zainer CM, Kubat CK, Mullen NK,
Windisch AK. The breast cancer epidemic: 10 facts. The
Linacre Quarterly 2014;81(3):244-277. Available at:<http://www.maneyonline.com/doi/pdfplus/10.1179/2050854914Y.0000000027>.
|
|
The Coalition
on Abortion/Breast Cancer is an international
women's organization founded to protect the health and save the
lives of women by educating and providing information on abortion
as a risk factor for breast cancer.
|
|
|
|
|
|
Copyright © 2014 Coalition On Abortion Breast Cancer,
All rights reserved.
You are receiving this email because you opted in at our website
Our mailing address is:
Coalition On Abortion Breast Cancer
PO Box 957133
Hoffman Estates, IL 60195-3051
|
|
|
|
|
|
|
|
|
No comments:
Post a Comment